Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03065166 · ClinicalTrials.gov registry record · NA

Dried Cabernet Grapes and Cardiovascular Risk Markers

A NA study, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT03065166: Completed NA study, sponsored by University of California, Davis.

NCT03065166 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03065166, a NA study, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

This study assesses the acute effects of dried Cabernet grape intake on vascular function and platelet reactivity in postmenopausal women. Previous studies from this lab and others have demonstrated acute effects on vascular function and platelet reactivity from phenolic-rich food sources. Postmenopausal women are suggested as the study group, as they are likely to have compromised vascular function due to the loss of protective estrogen, and have been the study group for past and present research projects in this lab.

Primary Outcome

To determine whether an acute intake of dried Cabernet grapes will improve vascular function, as measured using peripheral artery tonometry (PAT).

Interventions

  • OTHER Raisin Treatment
  • OTHER Bagel Control

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2016-09
Est. Completion 2017-07
Phase NA
University of California, Davis

657 total trials

What the finished NCT03065166 record still lists

NCT03065166 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Raisin Treatment is the first listed.

NCT03065166 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03065166 about?

NCT03065166 is a clinical study titled "Dried Cabernet Grapes and Cardiovascular Risk Markers". This study assesses the acute effects of dried Cabernet grape intake on vascular function and platelet reactivity in postmenopausal women. Previous studies from this lab and others have demonstrated acute effects on vascular function and platelet reactivity from phenolic-rich food sources. Postmenop...

What is the current status of trial NCT03065166?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-09. Estimated completion is 2017-07.

What interventions are being tested in trial NCT03065166?

The interventions under investigation include: Raisin Treatment (OTHER), Bagel Control (OTHER).

Who is sponsoring clinical trial NCT03065166?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03065166's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03065166, the US trial registry maintained by the National Library of Medicine. NCT03065166 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.